Abstract:Introduction: Costimulation blockade targeting the CD28 pathway provides improved long-term renal allograft survival compared to calcineurin inhibitors but may be limited as CTLA-4-Ig (abatacept, belatacept) blocks both CD28 costimulation and CTLA-4 coinhibition. Directly targeting CD28 while leaving CTLA-4 intact may provide a mechanistic advantage. Fc-silent non-crosslinking CD28 antagonizing domain antibodies (dAb) are currently in clinical trials for renal transplantation. Given the current standard of care in renal transplantation at most US centers, it is likely that lymphodepletion via thymoglobulin induction therapy could be used in patients treated with CD28 antagonists. Thus, we investigated the impact of T cell depletion (TCD) on T cell phenotype following homeostatic reconstitution in a murine model of skin transplantation treated with anti-CD28dAb. Methods: Skin from BALB/cJ donors was grafted onto C56BL/6 recipients which were treated with or without 0.2mg anti-CD4 and 10μg anti-CD8 one day prior to transplant and with or without 100μg anti-CD28dAb on days 0, 2, 4, 6, and weekly thereafter. Mice were euthanized six weeks post-transplant and lymphoid cells were analyzed by flow cytometry. Results: Anti-CD28dAb reversed lymphopenia-induced differentiation of memory CD4+ T cells in the spleen and lymph node compared to TCD alone. Mice treated with TCD+anti-CD28dAb exhibited significantly improved skin graft survival compared to anti-CD28dAb alone, which was also improved compared to no treatment. In addition, the expression of CD69 was reduced on CD4+ and CD8+ T cells in the spleen and lymph node from mice that received TCD+anti-CD28dAb compared to TCD alone. While a reduced frequency of CD4+FoxP3+ T cells was observed in anti-CD28dAb treated mice relative to untreated controls, this was balanced by an increased frequency of CD8+Foxp3+ T cells that was observed in the blood and kidney of mice given TCD+anti-CD28dAb compared to TCD alone. Discussion: These data demonstrate that CD28 signaling impacts the differentiation of both CD4+ and CD8+ T cells during homeostatic reconstitution following lymphodepletion, resulting in a shift towards fewer activated memory T cells and more CD8+FoxP3+ T cells, a profile that may underpin the observed prolongation in allograft survival.

CD28 costimulation is essential for human T regulatory expansion and function

Strong CD28 Costimulation Suppresses Induction of Regulatory T Cells from Naïve Precursors Through Lck Signaling.

T Cell Costimulation through CD28 Depends on Induction of the Bcl-xγ Isoform

T cell costimulation through CD28 depends on induction of the Bcl-xgamma isoform: analysis of Bcl-xgamma-deficient mice.

CD28 Costimulation: From Mechanism to Therapy

85: CD28 Controls Differentiation of Regulatory T Cells from Naive CD4 T Cells

Cd28 Controls Differentiation of Regulatory T Cells from Naive Cd4 T Cells

Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells.

CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4

CD28 engagement inhibits CD73-mediated regulatory activity of CD8+ T cells

Cd28 Costimulation Inhibits Tcr-Induced Apoptosis During A Primary T Cell Response

CD28 co-receptor signal transduction in T-cell activation

[CD28 costimulation and checkpoint inhibition in T cells]

B7-CD28 interaction promotes proliferation and survival but suppresses differentiation of CD4-CD8- T cells in the thymus.

Immunosuppression through biockade of CD28:B7-mediated costimulatory signals

Cd28 Co-Stimulation Restores T Cell Responsiveness In Nod Mice By Overcoming Deficiencies In Rac-1/P38 Mitogen-Activated Protein Kinase Signaling And Il-2 And Il-4 Gene Transcription

Selective CD28 blockade impacts T cell differentiation during homeostatic reconstitution following lymphodepletion

Transcriptional reprogramming via signaling domains of CD2, CD28 and 4-1BB

TGF-β Induces Foxp3 + T-Regulatory Cells from CD4 + CD25 − Precursors

Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway

Tregs from human blood differentiate into nonlymphoid tissue–resident effector cells upon TNFR2 costimulation